Back to top
more

Stryker (SYK)

(Delayed Data from NYSE)

$307.80 USD

307.80
3,427,831

+6.66 (2.21%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $307.00 -0.80 (-0.26%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 34% (175 out of 247)

Industry: Medical - Products

Zacks News

Zacks Equity Research

Here's Why You Should Hold AmerisourceBergen (ABC) Stock Now

Here we discuss the primary factors that are plaguing AmerisourceBergen (ABC) and the prospects that indicate near-term recovery.

    Zacks Equity Research

    Patterson Companies' (PDCO) Earnings Meet Estimates in Q4

    Lackluster sales and earnings performance dampened Patterson Companies' (PDCO) fourth-quarter results.

      Zacks Equity Research

      Is Stryker (SYK) Outperforming Other Medical Stocks This Year?

      Is Stryker Corporation (SYK) Outperforming Other Medical Stocks This Year?

        Zacks Equity Research

        Here's Why You Should Steer Clear of Cerner (CERN) for Now

        Cerner's (CERN) downbeat view for 2018 and soft segmental performances fail to cheer investors.

          Zacks Equity Research

          Masimo's (MASI) US Launch of TIR-1 to Aid Patient Monitoring

          Masimo (MASI) along with Thermomedics launches TIR-1 in the United States, market prospects look solid.

            Zacks Equity Research

            The Zacks Analyst Blog Highlights: Schlumberger, Walgreens Boots, BNY Mellon, Stryker and Duke Energy

            The Zacks Analyst Blog Highlights: Schlumberger, Walgreens Boots, BNY Mellon, Stryker and Duke Energy

              Mark Vickery headshot

              Top Analyst Reports for Schlumberger, Walgreens Boots & BNY Mellon

              Today's Research Daily features new research reports on 16 major stocks, including Schlumberger (SLB), Walgreens Boots (WBA) and BNY Mellon (BK).

                Zacks Equity Research

                Here's Why You Should Hold Onto DENTSPLY SIRONA Stock Now

                DENTSPLY SIRONA (XRAY) gains from its increasing focus on innovation while a lowered earnings guidance for 2018 raises concern.

                  Zacks Equity Research

                  Varian Medical's (VAR) ProBeam Platform Gains Foothold in UK

                  Varian Medical's (VAR) ProBeam system is the first of its kind to deliver intensity-modulated proton therapy.

                    Nabaparna Bhattacharya headshot

                    Mechatronics for Healthcare: 3 MedTech Stocks to Bet On

                    Here we analyze how Medical Mechatronics is creating new opportunities in MedTech for investors who are keen on putting their money in the healthcare space for longer-term gains.